Literature DB >> 2152929

Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid.

K Oishi1, B Zheng, J F Kuo.   

Abstract

The effects and modes of action of certain lipid second messengers and protein kinase C regulators, such as sphingosine, lysophosphatidylcholine (lyso-PC), and oleic acid, on Na,K-ATPase and sodium pump were examined. Inhibition of purified rat brain synaptosome Na,K-ATPase by these lipid metabolites, unlike that by ouabain, was subject to membrane dilution (i.e. inhibition being counteracted by increasing amounts of membrane lipids). Kinetic analysis, using the purified enzyme, indicated that sphingosine and lyso-PC were likely to interact, directly or indirectly, with Na+-binding sites of Na,K-ATPase located at the intracellular face of plasma membranes, a conclusion also supported by studies on Na,K-ATPase and 22Na uptake using the inside-out vesicles of human erythrocyte membranes. The studies also showed that ouabain (but not sphingosine and lyso-PC) increased the affinity constant (K0.5) for K+, whereas sphingosine and lyso-PC (but not ouabain) increased K0.5 for Na+. Sphingosine and lyso-PC inhibited 86Rb uptake by intact human leukemia HL-60 cells at potencies comparable to those for inhibitions of purified Na,K-ATPase and protein kinase C. It is suggested that Na,K-ATPase (sodium pump) might represent an additional target system, besides protein kinase C, for sphingosine and possibly other lipid second messengers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152929

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Secondary messengers and phospholipase A2 in auxin signal transduction.

Authors:  Günther F E Scherer
Journal:  Plant Mol Biol       Date:  2002 Jun-Jul       Impact factor: 4.076

2.  Partial characterization of the inhibitory effect of lipid peroxidation on the ouabain-insensitive Na-ATPase of rat kidney cortex plasma membranes.

Authors:  R Marín; A J Rodríguez; T Proverbio
Journal:  J Bioenerg Biomembr       Date:  1992-06       Impact factor: 2.945

3.  Protein kinase C phosphorylation of cardiac troponin T decreases Ca(2+)-dependent actomyosin MgATPase activity and troponin T binding to tropomyosin-F-actin complex.

Authors:  T A Noland; J F Kuo
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  Adipocyte dysfunction and hypertension.

Authors:  Junlan Zhou; Gangjian Qin
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

5.  Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes.

Authors:  E Liu; J I Goldhaber; J N Weiss
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Purification and characterization of a Na+, K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans.

Authors:  P Burth; M Younes-Ibrahim; F H Gonçalez; E R Costa; M V Faria
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

Review 7.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

8.  Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.

Authors:  T Hashizume; T Sato; T Fujii
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.

Authors:  Y Prinsloo; C E van Rensburg; R van der Walt; R Anderson
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

10.  GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.

Authors:  Alexander Bondarenko; Markus Waldeck-Weiermair; Shamim Naghdi; Michael Poteser; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.